Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v18-EN Version v9-EN
Language English English
Date Updated 2020-01-14 2020-01-13
Drug Identification Number 02428393 02428393
Brand name SODIUM THIOSULFATE INJECTION USP SODIUM THIOSULFATE INJECTION USP
Common or Proper name Sodium Thiosulfate Injection USP Sodium Thiosulfate Injection USP
Company Name HOPE PHARMACEUTICALS LTD HOPE PHARMACEUTICALS LTD
Ingredients SODIUM THIOSULFATE SODIUM THIOSULFATE
Strength(s) 250MG 250MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 x 50 mL Vials 1 x 50 mL Vials
ATC code V03AB V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-09-25 2019-09-25
Actual start date 2019-09-27 2019-09-27
Estimated end date 2020-01-13 2020-01-13
Actual end date 2020-01-13 2020-01-13
Shortage status Resolved Actual shortage
Company comments
Health Canada comments